Study of the Pathogenesis of Olfactory Disorders in COVID-19
NCT04366934 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26
Last updated 2025-09-22
Summary
This study is a case-control study to characterize the molecular and cellular anomalies of the olfactory epithelium of COVID-19 patients with isolated anosmia, by comparison with the olfactory epithelium of non-infected subjects.
Conditions
- Coronavirus Infection
- Severe Acute Respiratory Syndrome
- Sars-CoV2
Interventions
- OTHER
-
Nasal swab
Nasal swab
- OTHER
-
Taste and olfactory function evaluation
Taste and olfactory function evaluation
Sponsors & Collaborators
-
Hôpital Lariboisière, AP-HP
collaborator UNKNOWN -
Institut Pasteur
lead INDUSTRY
Principal Investigators
-
Françoise LAZARINI, PhD · Institut Pasteur
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-05-04
- Primary Completion
- 2020-10-29
- Completion
- 2020-10-29
Countries
- France
Study Locations
More Related Trials
-
Rapid Screening for Olfactory Disorders in Covid-19 Infection
NCT04696601 ·Status: WITHDRAWN ·Phase: NA
-
COVID-19 Anosmia Study
NCT04495816 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of the Persistence of SARS-CoV-2 in the Olfactory Mucosa of Patients With Prolonged Symptoms of COVID-19
NCT05220241 ·Status: COMPLETED ·Phase: NA
-
Administration of Systemic Corticosteroids and the Recovery of Gustatory Functions in Patients With COVID-19
NCT05148832 ·Status: COMPLETED ·Phase: NA
-
Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease
NCT04569825 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
NCT05855369 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy of Olfactive Training on Loss of Smell and Taste Caused by SARS CoV2 COVID-19 (Covid-Smell)
NCT07190911 ·Status: COMPLETED ·Phase: NA
-
Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)
NCT04374474 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Nasal Microbiome and Its Importance in Disease
NCT05061329 ·Status: RECRUITING
-
Characteristics of the Anosmic Olfactory Mucosa
NCT05562050 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Treatment Research of COVID-19-related Olfactory Dysfunction
NCT05421195 ·Status: UNKNOWN ·Phase: NA
-
Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
NCT05445921 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Determine the Tolerability of Intranasal LMN-301
NCT06030414 ·Status: COMPLETED ·Phase: PHASE1
-
Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction
NCT06204432 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Corticosteroid Nasal Spray in COVID-19 Anosmia
NCT04484493 ·Status: COMPLETED ·Phase: PHASE3
-
Stellate Ganglion Block with Lidocaine for the Treatment of COVID-19-Induced Parosmia
NCT06055270 ·Status: RECRUITING ·Phase: PHASE3
-
Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects
NCT04431908 ·Status: COMPLETED
-
Smell in Covid-19 and Efficacy of Nasal Theophylline
NCT04789499 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults
NCT00344942 ·Status: TERMINATED ·Phase: PHASE3
-
Ivermectin Nasal Drops in Post COVID-19 Parosmia
NCT05269030 ·Status: UNKNOWN ·Phase: PHASE2
-
Prospective Registery of Smell/Taste Clinic Ear/Nose/Throat
NCT06456008 ·Status: RECRUITING
-
"Platelet Rich Plasma for the Management of Post-Viral Olfactory Dysfunction.
NCT05666492 ·Status: UNKNOWN ·Phase: NA
-
Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
NCT05542095 ·Status: WITHDRAWN ·Phase: PHASE1
-
Acupuncture Therapy for COVID-Related Olfactory Loss
NCT04952389 ·Status: COMPLETED ·Phase: NA
-
Value of Platelet-Rich Plasma in Post Severe Acute Respiratory Syndrome Coronavirus 2
NCT05395845 ·Status: UNKNOWN ·Phase: EARLY_PHASE1